Letter: APRI and FIB-4 do not correlate with Fibrosure in the evaluation of liver fibrosis in hepatitis C patients

M Herman¹, O Okoji^{1

2}, D Castaneda¹, E Jirru¹, D Kotler^{1

2}

Affiliations

¹ Department of Medicine, Mount Sinai St. Luke's and Mount Sinai West, New York, NY, USA.
² Department of Gastroenterology, Mount Sinai St. Luke's and Mount Sinai West, New York, NY, USA.

Comment

M Herman et al. Aliment Pharmacol Ther. 2017 Jan.

. 2017 Jan;45(1):190-191.

doi: 10.1111/apt.13836.

M Herman¹, O Okoji^{1

2}, D Castaneda¹, E Jirru¹, D Kotler^{1

2}

¹ Department of Medicine, Mount Sinai St. Luke's and Mount Sinai West, New York, NY, USA.
² Department of Gastroenterology, Mount Sinai St. Luke's and Mount Sinai West, New York, NY, USA.

No abstract available

Comment on

Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B.
Houot M, Ngo Y, Munteanu M, Marque S, Poynard T. Houot M, et al. Aliment Pharmacol Ther. 2016 Jan;43(1):16-29. doi: 10.1111/apt.13446. Epub 2015 Oct 30. Aliment Pharmacol Ther. 2016. PMID: 26516104 Free PMC article.